Baxter International (BAX) Receivables - Other (2009 - 2025)

Baxter International (BAX) has 17 years of Receivables - Other data on file, last reported at $71.0 million in Q4 2025.

• On a quarterly basis, Receivables - Other rose 39.22% year-over-year to $71.0 million in Q4 2025; TTM through Dec 2025 was $71.0 million, a 39.22% increase from a year earlier, with the FY2025 full-year figure at $71.0 million, up 39.22% from the prior year.
• Receivables - Other for Q4 2025 stood at $71.0 million, up from $51.0 million in the prior quarter.
• Over the last five years, Receivables - Other for BAX reached as high as $81.0 million in Q4 2021 and fell as low as $7.0 million in Q1 2021.
• Historically, Receivables - Other has averaged $41.1 million across 5 years, with a median of $51.5 million in 2022.
• Across the five-year window, Receivables - Other sank 91.36% in 2021 and jumped 39.22% in 2025, its largest moves.
• Year by year, Receivables - Other stood at $81.0 million in 2021, then slumped by 35.8% to $52.0 million in 2022, then grew by 1.92% to $53.0 million in 2023, then slipped by 3.77% to $51.0 million in 2024, then jumped by 39.22% to $71.0 million in 2025.
• Per Business Quant data, the three most recent Receivables - Other figures were $71.0 million in Q4 2025, $51.0 million in Q4 2024, and $53.0 million in Q4 2023.